Centessa Pharmaceuticals plc (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

27.89

+1.95 (7.52%)

At close: Mar 24, 2026, 4:00 PM EDT

28.28

+0.39 (1.40%)

After-hours: Mar 24, 2026, 5:58 PM EDT

Centessa Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3,750	2,208	777	293	1,012	-
Market Cap Growth	75.23%	184.18%	165.01%	-71.03%	-	-
Enterprise Value	3,575	1,775	579	-83	433	-
Last Close Price	25.94	16.75	7.96	3.10	11.26	-
PS Ratio	246.85	-	113.40	-	-	-
PB Ratio	11.56	5.50	3.29	0.87	2.06	-
P/TBV Ratio	12.28	5.50	3.29	0.87	2.06	-
EV/Sales Ratio	238.32	-	84.53	-	-	-
Debt / Equity Ratio	0.39	0.29	0.36	0.21	0.15	1.82
Net Debt / Equity Ratio	-0.42	-0.91	-0.73	-0.96	-1.06	-0.52
Net Debt / EBITDA Ratio	0.60	1.82	1.01	1.54	3.73	0.15
Net Debt / FCF Ratio	0.71	2.56	1.07	1.61	3.81	0.15
Asset Turnover	0.03	-	0.02	-	-	-
Quick Ratio	10.25	9.10	7.51	10.97	24.84	1.18
Current Ratio	10.57	9.25	8.00	11.42	25.52	1.30
Return on Equity (ROE)	-60.62%	-73.93%	-52.79%	-52.24%	-154.41%	-
Return on Assets (ROA)	-25.26%	-26.82%	-26.61%	-24.48%	-27.16%	-
Return on Capital Employed (ROCE)	-51.00%	-38.80%	-53.40%	-51.80%	-23.00%	-337.00%
Earnings Yield	-6.55%	-10.67%	-19.44%	-73.73%	-37.73%	-
FCF Yield	-4.89%	-6.43%	-20.65%	-68.77%	-13.47%	-
Buyback Yield / Dilution	-25.82%	-19.02%	-2.97%	-24.26%	-401.11%	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q